Kazumi Hanawa Selected Research

beraprost

6/2008

[Evidence-based quality management of clinical formulations: determination of expiration date of powdered medicine prepared by grinding tablets].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazumi Hanawa Research Topics

Disease

2	Ototoxicity 10/2022 - 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 03/2024
1	Gram-Positive Bacterial Infections 01/2022
1	Sepsis (Septicemia) 01/2019
1	Infections 01/2019
1	Intractable Pain 01/2010
1	Muscle Spasticity (Spastic) 08/2008
1	Pulmonary Hypertension 06/2008
1	Flatulence 08/2007
1	Postoperative Pain 08/2007

Drug/Important Bio-Agent (IBA)

2	Vancomycin FDA LinkGeneric 03/2024 - 01/2022
2	Amikacin (A.M.K)FDA LinkGeneric 10/2022 - 01/2019
1	sarpogrelateIBA 01/2010
1	oxybutynin (Tavor)FDA LinkGeneric 08/2008
1	beraprostIBA 06/2008
1	Fentanyl (Sublimaze)FDA LinkGeneric 08/2007
1	Droperidol FDA LinkGeneric 08/2007
1	Ropivacaine (Naropin)FDA LinkGeneric 08/2007

Therapy/Procedure

2	Therapeutics 01/2019 - 08/2008
1	Intravesical Administration 08/2008
1	Epidural Analgesia 08/2007